KR910007541A - 백혈병 치료용 제약 조성물 - Google Patents

백혈병 치료용 제약 조성물

Info

Publication number
KR910007541A
KR910007541A KR1019900016445A KR900016445A KR910007541A KR 910007541 A KR910007541 A KR 910007541A KR 1019900016445 A KR1019900016445 A KR 1019900016445A KR 900016445 A KR900016445 A KR 900016445A KR 910007541 A KR910007541 A KR 910007541A
Authority
KR
South Korea
Prior art keywords
leukaemias
human
treatment
pharmaceutical composition
leukemia
Prior art date
Application number
KR1019900016445A
Other languages
English (en)
Other versions
KR0168420B1 (ko
Inventor
브랑델리 모
마랑닌쉬 도미니끄
Original Assignee
로우셀-우크라프
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로우셀-우크라프 filed Critical 로우셀-우크라프
Publication of KR910007541A publication Critical patent/KR910007541A/ko
Application granted granted Critical
Publication of KR0168420B1 publication Critical patent/KR0168420B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019900016445A 1989-10-17 1990-10-16 백혈병 치료용 제약 조성물 KR0168420B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8913546A FR2653020B1 (fr) 1989-10-17 1989-10-17 Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies.
FR89-13546 1989-10-17

Publications (2)

Publication Number Publication Date
KR910007541A true KR910007541A (ko) 1991-05-30
KR0168420B1 KR0168420B1 (ko) 1999-01-15

Family

ID=9386473

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900016445A KR0168420B1 (ko) 1989-10-17 1990-10-16 백혈병 치료용 제약 조성물

Country Status (13)

Country Link
US (1) US5582822A (ko)
EP (1) EP0426521B1 (ko)
JP (1) JP2961189B2 (ko)
KR (1) KR0168420B1 (ko)
AT (1) ATE103494T1 (ko)
AU (1) AU640173B2 (ko)
CA (1) CA2027725A1 (ko)
DE (1) DE69007744T2 (ko)
DK (1) DK0426521T3 (ko)
FR (1) FR2653020B1 (ko)
HU (1) HU206048B (ko)
OA (1) OA09317A (ko)
ZA (1) ZA907648B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671728B1 (fr) * 1991-01-17 1995-01-20 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des pneumathorax.
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5696079A (en) * 1993-05-19 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
US5419900A (en) * 1993-05-19 1995-05-30 The United States Of America As Represented By The Department Of Of Health And Human Services Immunologic enhancement with intermittent interleukin-2 therapy
AU2001259063A1 (en) 2000-04-12 2001-10-30 Human Genome Sciences, Inc. Albumin fusion proteins
US6852344B2 (en) * 2000-12-04 2005-02-08 Council Of Scientific And Industrial Research Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof
GB2372598A (en) * 2001-02-26 2002-08-28 Coppereye Ltd Organising data in a database
EP1463751B1 (en) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Albumin fusion proteins
US6967034B2 (en) * 2002-05-31 2005-11-22 Council Of Scientific And Industrial Research Herbal-based composition for treating acute and chronic myeloid leukemia
DE60206531T2 (de) * 2002-05-31 2006-07-13 Council Of Scientific & Industrial Research Ein kräutermolekül als potentielles anti-leukämisches arzneimittel
US20040006138A1 (en) 2002-07-08 2004-01-08 Council Of Scientific Pharmaceutical composition useful for treating chronic myeloid leukemia
US20070161704A1 (en) * 2002-07-08 2007-07-12 Council Of Scientific And Industrial Research Pharmaceutical composition useful for treating chronic myeloid leukemia
US20050282892A1 (en) * 2002-07-08 2005-12-22 Santu Bandyopadhyay Pharmaceutical composition useful for treating chronic myeloid leukemia
WO2004024171A1 (en) * 2002-09-16 2004-03-25 Vasogen Ireland Limited Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine)
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
US7357652B1 (en) * 2006-10-27 2008-04-15 Leviton Manufacturing Company, Inc. Modular wiring system with locking elements
US8206920B2 (en) * 2007-03-26 2012-06-26 Arnold Ganser Diagnostic assay for the specific treatment of acute myeloid leukemia
US10622768B1 (en) 2019-05-10 2020-04-14 Walter Morgan Cowham Methods and systems for a modular plug-in bus wiring system
US10971879B1 (en) 2020-08-12 2021-04-06 Cowham Innovations, LLC. Electrical connection forming tool
CN111821423B (zh) * 2020-08-17 2023-04-11 中南大学湘雅二医院 一种白介素2用于治疗慢性自发性荨麻疹的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
ZA888978B (en) * 1987-12-04 1990-07-25 Du Pont Immobilized interleukin 2 and interleukin 2 containing a carboxylterminal extension
ZA898139B (en) * 1988-11-17 1990-08-29 Hoffmann La Roche Recombinant interleukin-2 hybrid proteins

Also Published As

Publication number Publication date
DE69007744T2 (de) 1994-07-28
DK0426521T3 (da) 1994-05-02
EP0426521A1 (fr) 1991-05-08
KR0168420B1 (ko) 1999-01-15
HU906463D0 (en) 1991-04-29
DE69007744D1 (de) 1994-05-05
HUT55241A (en) 1991-05-28
AU6466790A (en) 1991-04-26
US5582822A (en) 1996-12-10
HU206048B (en) 1992-08-28
CA2027725A1 (fr) 1991-04-18
FR2653020B1 (fr) 1993-03-26
EP0426521B1 (fr) 1994-03-30
ATE103494T1 (de) 1994-04-15
AU640173B2 (en) 1993-08-19
JP2961189B2 (ja) 1999-10-12
FR2653020A1 (fr) 1991-04-19
ZA907648B (en) 1991-11-27
OA09317A (fr) 1992-09-15
JPH03193736A (ja) 1991-08-23

Similar Documents

Publication Publication Date Title
KR910007541A (ko) 백혈병 치료용 제약 조성물
DE69034244D1 (de) Zytotoxischer Lymphozyten-Reifefaktor 35kD Untereinheit und monoklonale Antikörper spezifisch dafür
NZ212632A (en) Tumor necrosis factor, its preparation and its use
HK65693A (en) Pharmaceutical composition containing a human granulocyte colony stimulating factor for the treatment of leukopenia
DE68928710T2 (de) T-Zellen-Wachstumsfaktor
EP0231819A3 (en) Pharmaceutical agent for the treatment of myelogenous leukemia
DK0452598T3 (da) Anvendelsen af et polypeptid med humant-inter-leukin-2-aktivitet til fremstilling af farmaceutiske præparater til behandling af primitiv pleuracancer
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ATE157544T1 (de) Verwendung von human-beta-interferon zur stimulierung der erythropoiesis
IE871358L (en) Interferon for carcinoma
ES2039276T3 (es) Uso de una combinacion de interferon gamma e interferon alfa para la preparacion de un medicamento para el tratamiento de ciertas leucemias.
KR920014480A (ko) 기흉 치료용 제약 조성물을 제조하기 위한 인간 인터류킨 2의 활성을 갖는 폴리펩티드의 용도
BG60657B2 (en) Human recombinant interleukin-2 muteins

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20101001

Year of fee payment: 13

EXPY Expiration of term